Stay updated on Dapagliflozin and Metformin in GDM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.

Latest updates to the Dapagliflozin and Metformin in GDM Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3 (v3.4.3 added, v3.4.2 removed).SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2 with no user-visible content changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1; this appears to be a minor platform update with no visible changes to the page content or trial details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a 'Show glossary' option and the labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' to the page. Removed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' from the page.SummaryDifference0.2%

- Check79 days agoChange DetectedRevision updated to v3.3.4; the previous revision v3.3.3 is replaced.SummaryDifference0.1%

Stay in the know with updates to Dapagliflozin and Metformin in GDM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin and Metformin in GDM Clinical Trial page.